255 results on '"Randell, Tabitha"'
Search Results
2. The effect of closed-loop glucose control on C-peptide secretion in youth with newly diagnosed type 1 diabetes: the CLOuD RCT
3. Novel missense ACAN gene variants linked to familial osteochondritis dissecans cluster in the C-terminal globular domain of aggrecan
4. Effect of 48 Months of Closed-Loop Insulin Delivery on Residual C-Peptide Secretion and Glycemic Control in Newly Diagnosed Youth With Type 1 Diabetes: A Randomized Trial.
5. National Service Evaluation of the Quality of Care for Children and Young People with Congenital Adrenal Hyperplasia in the UK: Survey Responses from Patients and Clinicians
6. Strategies for optimising blood glucose control in diabetes mellitus
7. Diabetic Ketoacidosis at Onset of Type 1 Diabetes and Glycemic Outcomes with Closed-Loop Insulin Delivery.
8. Gene expression signature predicts rate of type 1 diabetes progression
9. Impact of technology-based interventions for children and young people with type 1 diabetes on key diabetes self-management behaviours and prerequisites: a systematic review
10. Quality of Life in Children and Young People With Congenital Adrenal Hyperplasia—UK Nationwide Multicenter Assessment.
11. Variation in the reporting of glucose values during simultaneous glucose sensor wear.
12. SKIP (Supporting Kids with diabetes In Physical activity): Feasibility of a randomised controlled trial of a digital intervention for 9-12 year olds with type 1 diabetes mellitus
13. Paediatric Society and Hyperinsulinism charity national surveys on CGM access for patients with recurrent hypoglycaemia
14. CGM accuracy: Contrasting CE marking with the governmental controls of the USA ( FDA ) and Australia ( TGA ) – A narrative review
15. Evaluating the Impact of Applying Personal Glucose Targets in a Closed-Loop System for People With Type 1 Diabetes
16. Safety of User-Initiated Intensification of Insulin Delivery Using Cambridge Hybrid Closed-Loop Algorithm
17. Real world use of hybrid‐closed loop in children and young people with type 1 diabetes mellitus—a National Health Service pilot initiative in England
18. Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes
19. Case for funding of continuous glucose monitoring systems for patients with recurrent hypoglycaemia
20. Health status of children and young persons with congenital adrenal hyperplasia in the UK (CAH-UK): a cross-sectional multi-centre study
21. Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes
22. 288-OR: Effect of 24 Months of Optimised Glucose Control on Residual C-Peptide Secretion in Youth with New Onset Type 1 Diabetes (T1D)
23. Diagnosis and management of hypoglycaemia beyond the neonatal period
24. Novel missense ACAN gene variants linked to familial osteochondritis dissecans cluster in the C-terminal globular domain of aggrecan
25. CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review.
26. Real world use of hybrid‐closed loop in children and young people with type 1 diabetes mellitus—a National Health Service pilot initiative in England.
27. Neuroblastoma with concurrent X chromosome monosomy, a coincidence or an association?
28. Rapid-onset obesity, hypothalamic and autonomic dysregulation with neuroendocrine tumours: Can this be ROHHADNET?
29. Nottinghams Robin Hood approach to socioeconomic and ethnic disparities in paediatric diabetes
30. Paediatric society calls for a review of access to funding for continuous glucose monitoring systems for patients with recurrent hypoglycaemia
31. The use of urinary steroid profiles in monitoring therapy in children with 21-hydroxylase deficiency - results from the CAH-UK cohort study
32. General population screening for childhood type 1 diabetes: is it time for a UK strategy?
33. User Engagement With the CamAPS FX Hybrid Closed-Loop App According to Age and User Characteristics
34. Obesity-Associated GNAS Mutations and the Melanocortin Pathway
35. Transition to the adult diabetes clinic
36. General population screening for childhood type 1 diabetes: is it time for a UK strategy?
37. Adolescents’ Experiences of Using a Smartphone Application Hosting a Closed-loop Algorithm to Manage Type 1 Diabetes in Everyday Life: Qualitative Study
38. User Engagement With the CamAPS FX Hybrid Closed-Loop App According to Age and User Characteristics
39. Health Status of Children and Young Persons With Congenital Adrenal Hyperplasia in the United Kingdom: Results of a Multi-Center Cohort Study
40. Quality of Life in Children and Young People With Congenital Adrenal Hyperplasia in the United Kingdom - Nationwide Multicentre Assessment
41. GHD Diagnostics in Europe and the US:An Audit of National Guidelines and Practice
42. Diagnosis and management of hypoglycaemia beyond the neonatal period
43. Reduced brown adipose tissue‐associated skin temperature following cold stimulation in children and adolescents with type 1 diabetes
44. Safety of the Newer Inhaled Corticosteroids in Childhood Asthma
45. Developing a Best Practice Tariff in paediatric diabetes
46. A Missense Mutation in the Human Cytochrome b5 Gene causes 46,XY Disorder of Sex Development due to True Isolated 17,20 Lyase Deficiency
47. Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocol
48. Using referral rates for genetic testing to determine the incidence of a rare disease: The minimal incidence of congenital hyperinsulinism in the UK is 1 in 28,389
49. Effectiveness of home or hospital initiation of treatment at diagnosis for children with type 1 diabetes (DECIDE trial): a multicentre individually randomised controlled trial
50. Paediatric random glucose requests in primary care
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.